Effect of Music Therapy on the Anxiety Level of Patients During the Administration of Ocular Intravitreal Injections
1 other identifier
interventional
50
1 country
1
Brief Summary
Introduction Ocular intravitreal injection is a widely used ophthalmic invasive technique to administer medication directly inside the patient's eye. Despite being usually a quick and painless intervention, some patients report nervousness and anxiety before and during the procedure. Music therapy could help in assessing this discomfort, as previous studies have shown it can beneficial, specially helping to reduce anxiety levels. Objective This study aims to assess the effect of music therapy on patients undergoing intravitreal injections and how it affects their anxiety. Methods This is a randomized, prospective, single blind, clinical trial. Patients will be divided into two groups. Group A patients will listen to classical music during the procedure (intervention). Group B patients (control), will not listen to music during the procedure. All other aspects of the procedure will be the same for both groups. To analyze the impact music therapy, patients will fill in the STAI anxiety questionnaire and will be evaluated with the pain visual analogue scale (VAS) before and after the injection procedure. Expected results Subjects that undergo the procedure with music therapy are expected to experience less anxiety that the ones that do not. Less pain perception is also expected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2023
CompletedFirst Posted
Study publicly available on registry
June 15, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2024
CompletedMarch 5, 2024
March 1, 2024
2 months
May 28, 2023
March 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
STAI
Change in anxiety score test
Just before and immediately after intervention
Study Arms (2)
Intervention
EXPERIMENTALMusic played prior to intravitreal injection
Control
NO INTERVENTIONNo music played.
Interventions
Eligibility Criteria
You may qualify if:
- Patients must be at least 18 years old.
- Patients must have been prescribed an intravitreal injections of an anti-VEGF drug.
- Subjects must have undergone at least one previous intravitreal injection.
- Patients must fully understand the procedure and the project they will be participating in and agree on signing the informed consent.
You may not qualify if:
- Patients with a psychiatric diagnosis with the need to take anxiety medication.
- Patients that before the intervention took medication to relax, such as benzodiazepines or anxiolytics.
- Subjects with hearing difficulty.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eduard Pedemonte Sarrias
Manresa, Barcelona, 08243, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
May 28, 2023
First Posted
June 15, 2023
Study Start
December 1, 2023
Primary Completion
January 31, 2024
Study Completion
February 28, 2024
Last Updated
March 5, 2024
Record last verified: 2024-03